HY-W143216-1g
|
MedChemexpress LLC
|
Azure C [CAS 531-57-7]
|
|
|
|
HY-P72162-10ug
|
MedChemexpress LLC
|
CYGB, Rat (His-Myc)
|
|
|
|
HY-P72162-5ug
|
MedChemexpress LLC
|
CYGB, Rat (His-Myc)
|
|
|
|
HY-P72162-50ug
|
MedChemexpress LLC
|
CYGB, Rat (His-Myc)
|
|
|
|
HY-P71146-10ug
|
MedChemexpress LLC
|
PRDX5/Peroxiredoxin-5, Human (HEK293, His)
|
|
|
|
HY-P71146-50ug
|
MedChemexpress LLC
|
PRDX5/Peroxiredoxin-5, Human (HEK293, His)
|
|
|
|
HY-P71145-10ug
|
MedChemexpress LLC
|
PRDX6, Human (His)
|
|
|
|
HY-P71145-50ug
|
MedChemexpress LLC
|
PRDX6, Human (His)
|
|
|
|
HY-112841-10mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
HY-112841-100mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
HY-112841-25mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
HY-112841-5mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
HY-112841-50mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
HY-112841-500mg
|
MedChemexpress LLC
|
PTZ-343 [CAS 101199-38-6]
|
|
Cancer-programmed cell death
|
|
HY-15929-1g
|
MedChemexpress LLC
|
TBHBA [CAS 14348-40-4]
|
|
|
|
HY-15929-5g
|
MedChemexpress LLC
|
TBHBA [CAS 14348-40-4]
|
|
|
|
HY-15929-1mL
|
MedChemexpress LLC
|
TBHBA [CAS 14348-40-4] (10mM in DMSO)
|
|
|
|
HY-155639-10mg
|
MedChemexpress LLC
|
Tyramide alkyne [CAS 2230051-33-7]
|
|
|
|
HY-155639-100mg
|
MedChemexpress LLC
|
Tyramide alkyne [CAS 2230051-33-7]
|
|
|
|
HY-155639-25mg
|
MedChemexpress LLC
|
Tyramide alkyne [CAS 2230051-33-7]
|
|
|
|
HY-155639-5mg
|
MedChemexpress LLC
|
Tyramide alkyne [CAS 2230051-33-7]
|
|
|
|
HY-155639-50mg
|
MedChemexpress LLC
|
Tyramide alkyne [CAS 2230051-33-7]
|
|
|
|
HY-D1837-10uL
|
MedChemexpress LLC
|
Vari Fluor 488 TSA?200�?
|
|
|
|
HY-D1837-100uL
|
MedChemexpress LLC
|
Vari Fluor 488 TSA?200�?
|
|
|
|
HY-D1832-10uL
|
MedChemexpress LLC
|
Vari Fluor 532 TSA (200�)
|
|
|
|